{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:21:21Z","timestamp":1790875281974,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.cll.2009.12.001","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T12:32:01Z","timestamp":1275395521000},"page":"161-177","source":"Crossref","is-referenced-by-count":116,"title":["Ebola and Marburg Hemorrhagic Fever"],"prefix":"10.1016","volume":"30","author":[{"given":"Amy L.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Towner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cll.2009.12.001_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/JVI.36.2.465-469.1980","article-title":"Virion nucleic acid of Ebola virus","volume":"36","author":"Regnery","year":"1980","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.cll.2009.12.001_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/oxfordjournals.molbev.a025820","article-title":"The origin and evolution of Ebola and Marburg viruses","volume":"14","author":"Suzuki","year":"1997","journal-title":"Mol Biol Evol"},{"issue":"11","key":"10.1016\/j.cll.2009.12.001_bib3","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib4","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/514285","article-title":"Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation","volume":"179","author":"Formenty","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2009.12.001_bib5","author":"World Health Organization"},{"key":"10.1016\/j.cll.2009.12.001_bib6","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.cll.2009.12.001_bib7","author":"World Health Organization"},{"key":"10.1016\/j.cll.2009.12.001_bib8","series-title":"Biosafety in microbiological and biomedical laboratories","author":"US Department of Health and Human Services","year":"2007"},{"key":"10.1016\/j.cll.2009.12.001_bib9","series-title":"Fields virology","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola viruses","author":"Sanchez","year":"2007"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2009.12.001_bib10","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1086\/520543","article-title":"Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment","volume":"196","author":"Colebunders","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib11","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/514321","article-title":"Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Ksiazek","year":"1999","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.cll.2009.12.001_bib12","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J Virol"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2009.12.001_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-59949-1_7","article-title":"Pathologic features of filovirus infections in humans","volume":"235","author":"Zaki","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8276","key":"10.1016\/j.cll.2009.12.001_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(82)91871-2","article-title":"Marburg-virus disease in Kenya","volume":"1","author":"Smith","year":"1982","journal-title":"Lancet"},{"issue":"6086","key":"10.1016\/j.cll.2009.12.001_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","article-title":"A case of Ebola virus infection","volume":"2","author":"Emond","year":"1977","journal-title":"Br Med J"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib17","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.cll.2009.12.001_bib18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10.1016\/j.cll.2009.12.001_bib19","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.cll.2009.12.001_bib20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.cll.2009.12.001_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.cll.2009.12.001_bib24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2009.12.001_bib25","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cll.2009.12.001_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.cll.2009.12.001_bib27","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/JVI.73.4.3491-3496.1999","article-title":"Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells","volume":"73","author":"Harcourt","year":"1999","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.cll.2009.12.001_bib28","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/JVI.02344-07","article-title":"Inhibition of IRF-3 activation by VP35 is critical for the high virulence of Ebola virus","volume":"82","author":"Hartman","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.cll.2009.12.001_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virol.2004.07.006","article-title":"A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus","volume":"328","author":"Hartman","year":"2004","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.cll.2009.12.001_bib30","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.cll.2009.12.001_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.it.2004.07.002","article-title":"Emerging roles of tissue factor in viral hemorrhagic fever","volume":"25","author":"Ruf","year":"2004","journal-title":"Trends Immunol"},{"issue":"13","key":"10.1016\/j.cll.2009.12.001_bib32","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.00069-06","article-title":"Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola","volume":"80","author":"Towner","year":"2006","journal-title":"J Virol"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2009.12.001_bib33","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1086\/520601","article-title":"High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings","volume":"196","author":"Towner","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2009.12.001_bib34","author":"Centers for Disease Control and Prevention"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2009.12.001_bib35","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1086\/520545","article-title":"Assessment of the risk of Ebola virus transmission from bodily fluids and fomites","volume":"196","author":"Bausch","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2009.12.001_bib36","first-page":"141","article-title":"Patients infected with high-hazard viruses: scientific basis for infection control","volume":"11","author":"Peters","year":"1996","journal-title":"Arch Virol Suppl"},{"issue":"11","key":"10.1016\/j.cll.2009.12.001_bib37","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3201\/eid0911.030339","article-title":"Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda","volume":"9","author":"Francesconi","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2009.12.001_bib38","first-page":"997","article-title":"Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread","volume":"61","author":"Baron","year":"1983","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib39","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1086\/514320","article-title":"Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Kerstiens","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib40","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1086\/514290","article-title":"Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues","volume":"179","author":"Georges","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2009.12.001_bib41","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.01.152","article-title":"Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions","volume":"78","author":"Bausch","year":"2008","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.cll.2009.12.001_bib43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.vaccine.2006.09.076","article-title":"Protective efficacy of neutralizing antibodies against Ebola virus infection","volume":"25","author":"Takada","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib44","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2009.12.001_bib45","first-page":"135","article-title":"Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses","volume":"11","author":"Jahrling","year":"1996","journal-title":"Arch Virol Suppl"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2009.12.001_bib46","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib47","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog"},{"issue":"Suppl 4","key":"10.1016\/j.cll.2009.12.001_bib48","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2009.12.001_bib49","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.cll.2009.12.001_bib50","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","article-title":"Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference","volume":"193","author":"Geisbert","year":"2006","journal-title":"J Infect Dis"},{"issue":"9400","key":"10.1016\/j.cll.2009.12.001_bib51","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(02)00018-9","article-title":"3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice","volume":"55","author":"Bray","year":"2002","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.cll.2009.12.001_bib53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(00)00066-8","article-title":"Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor","volume":"45","author":"Bray","year":"2000","journal-title":"Antiviral Res"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2009.12.001_bib54","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever","volume":"196","author":"Hensley","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib55","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.cll.2009.12.001_bib56","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.vaccine.2006.11.037","article-title":"Status and challenges of filovirus vaccines","volume":"25","author":"Reed","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.cll.2009.12.001_bib57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3201\/eid0805.010284","article-title":"Evaluation in nonhuman primates of vaccines against Ebola virus","volume":"8","author":"Geisbert","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1\u20133","key":"10.1016\/j.cll.2009.12.001_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-1656(95)00104-2","article-title":"Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys","volume":"44","author":"Ignatyev","year":"1996","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.cll.2009.12.001_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(03)00273-6","article-title":"Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein","volume":"40","author":"Swenson","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2009.12.001_bib60","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J\u00a0Infect Dis"},{"issue":"23","key":"10.1016\/j.cll.2009.12.001_bib61","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"Swenson","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cll.2009.12.001_bib62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.7.4.417","article-title":"Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses","volume":"7","author":"Swenson","year":"2008","journal-title":"Expert Rev Vaccines"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271209001280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271209001280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T06:59:43Z","timestamp":1591340383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271209001280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0272271209001280"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2009.12.001","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}